In addition, OHSS is a preventable condition and implementation of evidence-based prevention strategies enables clinicians to reduce its occurrence, and there are many evidences showing significantly lower rate of OHSS in GnRH-ant protocol [19–21]. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.